Bell Investment Advisors, Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Bell Investment Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $42 - $62	2 Added 11.76%	19 $0
Q3 2023 Nov 08, 2023	BUY	$26.2 - $36.08 $445 - $613	17 New	17 $0
Q4 2022 Feb 08, 2023	BUY	$28.0 - $40.56 $448 - $648	16 New	16 $0
Q2 2022 Aug 12, 2022	BUY	$27.79 - $50.61 $444 - $809	16 Added 114.29%	30 $1,000
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $813 - $1,155	14 New	14 $1,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.